A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
Authors
Keywords
-
Journal
npj Vaccines
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-28
DOI
10.1038/s41541-023-00763-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021
- (2022) Keli N. Gerken et al. PLoS Neglected Tropical Diseases
- Development of mRNA vaccines against respiratory syncytial virus (RSV)
- (2022) Xirui Qiu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Immune correlates of protection following Rift Valley fever virus vaccination
- (2022) Joshua D. Doyle et al. npj Vaccines
- An Overview of Rift Valley Fever Vaccine Development Strategies
- (2022) Paul Kato Kitandwe et al. Vaccines
- Arm race between Rift Valley fever virus and host
- (2022) Xiao Wang et al. Frontiers in Immunology
- Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge
- (2022) Ting Bian et al. Frontiers in Immunology
- Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial
- (2021) Cassandra Aldrich et al. VACCINE
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
- (2021) Paul J. Wichgers Schreur et al. Vaccines
- mRNA vaccines for infectious diseases: principles, delivery and clinical translation
- (2021) Namit Chaudhary et al. NATURE REVIEWS DRUG DISCOVERY
- Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
- (2020) Meng Hao et al. Viruses-Basel
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- A protective bivalent vaccine against Rift Valley fever and bluetongue
- (2020) Eva Calvo-Pinilla et al. npj Vaccines
- Rift Valley Fever Virus Is Lethal in Different Inbred Mouse Strains Independent of Sex
- (2020) Haley N. Cartwright et al. Frontiers in Microbiology
- T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
- (2019) Shane Crotty IMMUNITY
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus
- (2019) Qihui Wang et al. Nature Microbiology
- Comparison of DNA and mRNA vaccines against cancer
- (2019) Zohreh Jahanafrooz et al. DRUG DISCOVERY TODAY
- Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models
- (2018) Qiang Guo et al. JOURNAL OF INFECTIOUS DISEASES
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting
- (2018) Tiphany Chrun et al. npj Vaccines
- A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus
- (2018) Elizabeth R. Allen et al. Cell Reports
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope
- (2017) Yan Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rift Valley Fever: An Emerging Mosquito-Borne Disease
- (2016) Kenneth J. Linthicum et al. Annual Review of Entomology
- Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, andToxoplasma gondiichallenges with a single dose
- (2016) Jasdave S. Chahal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
- (2016) Margit Schnee et al. PLoS Neglected Tropical Diseases
- Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission
- (2016) Paul J. Wichgers Schreur et al. Frontiers in Microbiology
- Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study
- (2016) Moataz Alhaj Journal of Immunology Research
- Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
- (2016) George M. Warimwe et al. Scientific Reports
- Rift Valley Fever Virus Incorporates the 78 kDa Glycoprotein into Virions Matured in Mosquito C6/36 Cells
- (2014) Hana M. Weingartl et al. PLoS One
- Risk factors associated with human Rift Valley fever infection: systematic review and meta-analysis
- (2014) Dennis E. Nicholas et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Mapping the crossroads of immune activation and cellular stress response pathways
- (2013) Nuno Cláudio et al. EMBO JOURNAL
- Crystal structure of glycoprotein C from Rift Valley fever virus
- (2013) M. Dessau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
- (2013) George M Warimwe et al. Virology Journal
- Efficacy of three candidate Rift Valley fever vaccines in sheep
- (2012) J. Kortekaas et al. VACCINE
- The Pathogenesis of Rift Valley Fever
- (2011) Tetsuro Ikegami et al. Viruses-Basel
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR−/− mice induced by different DNA vaccination regimens
- (2010) Gema Lorenzo et al. VACCINE
- Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever Virus
- (2010) Nitin Bhardwaj et al. PLoS Neglected Tropical Diseases
- Case report: Rift Valley Fever with vertical transmission in a pregnant Sudanese woman
- (2008) Ishag Adam et al. JOURNAL OF MEDICAL VIROLOGY
- Multiple Virus Lineages Sharing Recent Common Ancestry Were Associated with a Large Rift Valley Fever Outbreak among Livestock in Kenya during 2006-2007
- (2008) B. H. Bird et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started